Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2026-03-27 Regulatory Filings
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the closure of the trading window for insiders due to SEBI regulations on insider trading. It specifies the dates for the trading window closure and reopening around the announcement of financial results for the quarter and year ended 31 March 2026. The document does not contain any financial data, results, or detailed report content. It is an announcement related to compliance and trading restrictions, not a financial report or earnings release. The document length is short (2102 characters) and serves as a regulatory compliance notice. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2026-03-27 English
Updates
Board/Management Information Classification · 100% confidence The document is a formal disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, announcing the constitution of an Advisory Board by the company's Board of Directors. It includes details about the Advisory Board members, their profiles, and the advisory role of the board. There is no financial data, earnings information, or report attached or referenced as being published. The document is an announcement of a board/management related change, specifically the formation of an advisory board, which falls under Board/Management Information category. The document length is 9313 characters, which is substantial but the content is clearly about management structure and advisory board formation, not a financial report or regulatory filing of other types.
2026-03-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the schedule of an Investors / Analysts Meet. It references compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure obligations. The content is an announcement of a meeting schedule, not a financial report or detailed presentation. The document length is only 1756 characters, indicating it is brief and informational. It does not contain financial data, management discussion, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-03-16 English
Allotment of Securities
Capital/Financing Update Classification · 100% confidence The document is a formal disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the allotment of equity shares by way of preferential issue on a private placement basis. It details the number of shares issued, the price, the investor involved, and the impact on the company's paid-up equity share capital. The document is addressed to stock exchanges and includes regulatory references and compliance information. It is an announcement of a capital raising event and share allotment, not a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a report publication notice but a substantive disclosure about financing activity.
2026-03-13 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the approval of the closure (dissolution) of a step-down subsidiary. It references a prior board approval and cites compliance with SEBI Listing Obligations Regulation 30, which pertains to material events disclosures. The document does not contain financial statements, detailed reports, or management discussion. It is an announcement of a corporate event (subsidiary closure) rather than a full report or detailed filing. The length is only 1901 characters, indicating it is a brief announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-23 English
Credit Rating
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges regarding a credit rating reaffirmation by ACUITE Ratings & Research Limited. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an intimation or announcement about credit rating status, not a full financial report or detailed analysis. The document length is 2182 characters, which is short and primarily serves as a regulatory disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-17 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.